IndraLab

Statements


USP14 inhibits NLRC5. 5 / 6
| 5

reach
"Next, we tested whether USP14 also enhanced NLRC5 mediated inhibition of TRAF2/6 independent noncanonical NF-kappaB signaling."

reach
"USP14-mediated NLRC5 upregulation inhibits endothelial cell activation and inflammation in atherosclerosis."

reach
"These results suggest that USP14 specifically enhanced NLRC5 mediated inhibition of NF-kappaB activation through the inhibition of NLRC5 ubiquitination via its DUB activity."

reach
"Because USP14 specifically enhanced NLRC5 mediated inhibition of NF-kappaB activation, we reasoned that USP14 deficiency would result in the accumulation of ubiquitinated NLRC5 and increased NF-kappaB activation under physiological conditions."

reach
"These results suggest that USP14 inhibits NF-kappaB signaling in an NLRC5 dependent manner."